“Safety And Tolerability Of Chikungunya Virus-Like Particle Vaccine In Healthy Adults: A Phase 1 Dose-Escalation Trial.”. Lancet 384 (9959). Lancet: 2046-52. doi:10.1016/S0140-6736(14)61185-5.
. 2014. “Protection Against Malaria By Intravenous Immunization With A Nonreplicating Sporozoite Vaccine.”. Science 341 (6152). Science: 1359-65. doi:10.1126/science.1241800.
. 2013.